HEA

Exclusive: China in talks with Pfizer for generic COVID drug

by

HONG KONG/BEIJING, Jan 6 (Reuters) – China is in talks with Pfizer Inc (PFE.N) to secure a license that will allow domestic drugmakers to manufacture and distribute a generic version of the US firm’s COVID-19 antiviral drug Paxlovid in China, three sources told Reuters. China’s medical products regulator – the National Medical Products Administration (NMPA) … Read more

Travel curbs rack up as COVID-hit China readies reopening

by

China to drop quarantine for overseas visitors on Sunday Greece joins nations imposing travel curbs on China Travel rush, holidays could inflame virus outbreak SHANGHAI/BEIJING, Jan 6 (Reuters) – More countries around the world are demanding that visitors from China take COVID tests, days before it drops border controls and ushers in an eagerly awaited … Read more